Related Experiment Video
Updated: Aug 9, 2026
11:41
Evaluation of an Exclusive Spur Dike U-Turn Design with Radar-Collected Data and Simulation
Published on: February 1, 2020
Type 2 diabetes express highway, where is the 'U' turn?
1Ambika Clinic and Research Centre, A/224, Kasturi Plaza, Manpada Road, Dombivili (E), Dist. Thane-421 201, India.
The Journal of the Association of Physicians of India
|September 17, 2003
Summary
Reversing Type 2 Diabetes involves lifestyle changes, integrating traditional practices with modern technology for enhanced well-being. This approach differentiates technology for comfort versus technology for genuine happiness.
Area of Science:
- Lifestyle Medicine
- Behavioral Science
- Health Technology
Background:
- Type 2 Diabetes (T2D) management often focuses on medical interventions.
- The role of lifestyle modifications in T2D remission is increasingly recognized.
- The impact of technology on patient happiness and adherence is under-explored.
Purpose of the Study:
- To explore the potential of integrating traditional lifestyles with modern technology for Type 2 Diabetes management.
- To differentiate between technology promoting comfort and technology fostering happiness in T2D patients.
Main Methods:
- Qualitative analysis of existing literature on T2D, lifestyle, and technology.
- Conceptual framework development integrating traditional practices and technological applications.
- Review of studies examining technology's impact on well-being and happiness.
Main Results:
- A 'U' turn in Type 2 Diabetes management may be achieved through strategic lifestyle modifications.
- Traditional lifestyles, when enhanced by specific modern technologies, can lead to improved patient happiness.
- A clear distinction exists between technologies designed for mere comfort and those that genuinely enhance happiness.
Conclusions:
- Lifestyle modifications are pivotal for Type 2 Diabetes reversal.
- Integrating traditional lifestyles with happiness-focused technology offers a novel therapeutic avenue.
- Future research should focus on developing and validating happiness-centric technological interventions for chronic disease management.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...